ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 649091 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 649091; 2) Community: the network communities that were significantly associated with the response to NSC 649091; 3) Molecule: the relationships between components within communities and NSC 649091; 4) MDR: the compounds that were significantly associated with the NSC 649091.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0228801759885691 0.33938706
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0228801759885691 0.36434975
NSC 732178 Null 0.0228801759885691 0.36555494
NSC 733467 Null 0.0228801759885691 0.21817107
NSC 740 Methotrexate 0.0228801759885691 0.42926327
NSC 746540 Null 0.0228801759885691 0.44039216
NSC 747461 Null 0.0228801759885691 -0.031481441
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0228801759885691 0.26144737
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0228801759885691 0.43015997
NSC 87222 ACTINOMYCIN C3 0.0228801759885691 0.32071799
Total:112  Current:65    [First] [Prev] [Next] [Last]